Global Brain has invested in Olive Corporation (Olive), a provider of an emotion estimation platform, through its Canon Marketing Japan MIRAI Fund (Canon MJ MIRAI Fund) as the lead investor. Olive is a company that elucidates the causal relationship between emotions and human behavior such as decision-making through the analysis of biological data. Emotion estimation using biological data is more accurate compared to conventional methods based on facial expressions and voice. This new way of estimating emotions has been garnering attention, with research and development spurred by the recent proliferation of wearable devices. Furthermore, while facial expressions and voice present challenges as they are not always clearly exhibited when a person is alone, biological data can be measured regardless of the situation. Olive’s emotion estimation platform, LaCause, features the ability to easily measure biological data and achieve high-precision emotion estimation. It is already being utilized in a wide range of markets, including health and productivity management, education, tourism, retail, healthcare, and entertainment. Global Brain has decided to invest in Olive based on its high regard for Olive’s advanced technological capabilities and the strength of its team in co-creating new businesses that leverage emotions with its clients. Through this investment, Global Brain will actively support Olive’s further business growth.

About Olive

Location: Nagoya-shi, Aichi, Japan
Representative: Seiji Takeuchi
Founded: August 2022
URL: https://www.01ive.co.jp/

About Canon MJ MIRAI Fund

Name: Canon Marketing Japan MIRAI Fund L.P.
General Partner: Global Brain Corporation

About Global Brain

Location: Tokyo, Japan
Representative: Yasuhiko Yurimoto
Founded: January 1998
URL: https://globalbrains.com

Global Brain has invested in Olive Corporation, a provider of an emotion estimation platform, as the lead investor